Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism

NPJ Vaccines. 2022 May 25;7(1):56. doi: 10.1038/s41541-022-00479-9.

Abstract

‘Affinity escape’: Novel SARS-CoV-2 variants may escape immunity by raising the RBD-ACE2 affinity high enough to outcompete the avidity of neutralizing antibodies.